Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...

China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to Merck for about $500 million. WuXi had ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, to make oral ...

With cases of Feline Infectious Peritonitis (FIP) on rise in China, cat owners are making their pets pop in Covid-19 drugs as antidotes. But is it safe, and why are they doing so?

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

APPA-02 is under development for the treatment of multidrug-resistant chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients and non-CF bronchiectasis (NCFB). The drug ...

German stocks are modestly higher Monday morning with investors reacting to data on Germany's composite and services sector PMI ...

The Thyroid Function Test (TFT) market in India is gaining significant traction as a crucial diagnostic tool for identifying thyroid disorders, ...

Prodeon Medical, Inc., a medical device company developing a minimally invasive treatment for lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia ...

Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its Chief ...

Merck, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...